FeesSafety
Pluang+

Nvidia's AI growth outpaces Eli Lilly's drug sales for next decade potential

Market News
21 Sep 2026, 17:30 WIB
24/7 Wall Street
View Source
Bullish
Nvidia's AI growth outpaces Eli Lilly's drug sales for next decade potential

Nvidia and Eli Lilly both exceeded earnings expectations, but Nvidia's AI-driven data center growth offers a stronger long-term investment opportunity. Nvidia posted $96.22 billion in revenue, driven by AI infrastructure demand and supply constraints, with forecasts of 70% growth next fiscal year. Eli Lilly reported $22.97 billion, boosted by GLP-1 drugs like Mounjaro, but faces risks from drug price declines and product concentration. Nvidia's platform expansion and high margins position it better for the next decade, while Lilly suits more defensive investors seeking dividends and lower volatility.

Nvidia's market cap stands at $5.37 trillion as of Sep 21, 2026, highlighting its dominant position in the tech sector, compared to Eli Lilly's $1.03 trillion in health care. On Pluang, Nvidia shares trade at USD 224.56 with a 1.03% gain over the day, while Eli Lilly is priced at USD 1,166.87, up 1.27% as of the same time. Nvidia's typical hold time on Pluang is longer at 114 days, reflecting possibly greater investor confidence in its growth potential as of Sep 21, 2026 21:44 WIB.

More News (NVDA)

Anthropic's IPO tests Big Tech's bets with billions committed to AI cloud and chip deals.

Anthropic's IPO tests Big Tech's bets with billions committed to AI cloud and chip deals.

Anthropic, the AI company behind the Claude model, is preparing for its initial public offering, marking a significant moment for Wall Street and major tech firms. Big tech players like Alphabet, Amazon, and Microsoft have committed tens of billions ...

Market News
Bullish
9 hours ago
IonQ stock falls 32% in a month despite record revenue and big deals, sparking debate on its future.

IonQ stock falls 32% in a month despite record revenue and big deals, sparking debate on its future.

IonQ's stock dropped 32% in the past month amid a sector-wide decline in quantum computing shares, despite the company posting record revenue growth and securing major deals like a partnership with NVIDIA and a $1.8 billion acquisition of SkyWater Te...

Market News
Neutral
10 hours ago
NVIDIA stock rises 3% despite warnings of Chinese AI chip competition, with AMD and Broadcom also gaining.

NVIDIA stock rises 3% despite warnings of Chinese AI chip competition, with AMD and Broadcom also gaining.

NVIDIA shares climbed 3% after a CEO of a startup backed by NVIDIA warned that Chinese AI labs might sell chips abroad alongside open-source AI models, posing a competitive threat. Despite this, investors remain optimistic, partly due to NVIDIA tradi...

Market News
Bullish
11 hours ago
NVIDIA shares fall 13% despite doubling revenue, seen as a strong buy amid AI growth and solid fundamentals.

NVIDIA shares fall 13% despite doubling revenue, seen as a strong buy amid AI growth and solid fundamentals.

NVIDIA's stock dropped 13.63% in a month while its revenue doubled, presenting a buying opportunity for investors confident in its AI-driven growth. The company reported strong Q2 fiscal 2027 results with revenue up 105.8% year-over-year and consecut...

Market News
Bullish
12 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
13 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App